Global Metabolomics Market By Product Type (Metabolomics Instruments, Separation Tools (Gas Chromatography, Ultra-performance Liquid Chromatography, High-performance Liquid Chromatography, and Capillary Electrophoresis), Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectroscopy, and Surface-based Mass Analysis)), By Indication (Cancer, Neurological Disorders, Metabolic Disorders, Cardiovascular Disorders, and Others), By Application (Biomarker Discovery, Toxicology Testing, Personalized Medicine, Nutrogenomics, Functional Genomics, Drug Discovery, and Others), By End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Contract Research Organizations), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Metabolomics Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Metabolomics Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Metabolomics Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 3.3. Global Metabolomics Market Attractiveness Analysis, By Product Type
    • 3.3.1. Metabolomics Instruments
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Separation Tools
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
        • 3.3.2.2.1. Gas Chromatography
        • 3.3.2.2.2. Ultra-performance Liquid Chromatography
        • 3.3.2.2.3. High-performance Liquid Chromatography
        • 3.3.2.2.4. Capillary Electrophoresis
    • 3.3.3. Detection Tools
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
        • 3.3.3.2.1. Nuclear Magnetic Resonance (NMR) Spectroscopy
        • 3.3.3.2.2. Mass Spectroscopy
        • 3.3.3.2.3. Surface-based Mass Analysis
  • 3.4. Global Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 3.5. Global Metabolomics Market Attractiveness Analysis, By Indication
    • 3.5.1. Cancer
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Neurological Disorders
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Metabolic Disorders
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. Cardiovascular Disorders
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
    • 3.5.5. Others
      • 3.5.5.1. Insights
      • 3.5.5.2. Key Takeaways
  • 3.6. Global Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 3.7. Global Metabolomics Market Attractiveness Analysis, By Application
    • 3.7.1. Biomarker Discovery
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Toxicology Testing
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Personalized Medicine
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
    • 3.7.4. Nutrogenomics
      • 3.7.4.1. Insights
      • 3.7.4.2. Key Takeaways
    • 3.7.5. Functional Genomics
      • 3.7.5.1. Insights
      • 3.7.5.2. Key Takeaways
    • 3.7.6. Drug Discovery
      • 3.7.6.1. Insights
      • 3.7.6.2. Key Takeaways
    • 3.7.7. Others
      • 3.7.7.1. Insights
      • 3.7.7.2. Key Takeaways
  • 3.8. Global Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 3.9. Global Metabolomics Market Attractiveness Analysis, By End-user
    • 3.9.1. Academic & Research Institutes
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Pharmaceutical & Biotechnology Companies
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
    • 3.9.3. Contract Research Organizations
      • 3.9.3.1. Insights
      • 3.9.3.2. Key Takeaways
• 4. Global Metabolomics Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Metabolomics Market Attractiveness Analysis, By Region
• 5. North America Metabolomics Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 5.3. North America Metabolomics Market Attractiveness Analysis, By Product Type
  • 5.4. North America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 5.5. North America Metabolomics Market Attractiveness Analysis, By Indication
  • 5.6. North America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 5.7. North America Metabolomics Market Attractiveness Analysis, By Application
  • 5.8. North America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 5.9. North America Metabolomics Market Attractiveness Analysis, By End-user
  • 5.10. North America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.11. North America Metabolomics Market Attractiveness Analysis, By Country
    • 5.11.1. The US
    • 5.11.2. Canada
• 6. Europe Metabolomics Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 6.3. Europe Metabolomics Market Attractiveness Analysis, By Product Type
  • 6.4. Europe Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 6.5. Europe Metabolomics Market Attractiveness Analysis, By Indication
  • 6.6. Europe Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 6.7. Europe Metabolomics Market Attractiveness Analysis, By Application
  • 6.8. Europe Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 6.9. Europe Metabolomics Market Attractiveness Analysis, By End-user
  • 6.10. Europe Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.11. Europe Metabolomics Market Attractiveness Analysis, By Country
    • 6.11.1. Germany
    • 6.11.2. The UK
    • 6.11.3. France
    • 6.11.4. Spain
    • 6.11.5. Italy
    • 6.11.6. Russia
    • 6.11.7. Netherland
    • 6.11.8. Rest of Europe
• 7. Asia Pacific Metabolomics Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 7.3. Asia Pacific Metabolomics Market Attractiveness Analysis, By Product Type
  • 7.4. Asia Pacific Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 7.5. Asia Pacific Metabolomics Market Attractiveness Analysis, By Indication
  • 7.6. Asia Pacific Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 7.7. Asia Pacific Metabolomics Market Attractiveness Analysis, By Application
  • 7.8. Asia Pacific Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 7.9. Asia Pacific Metabolomics Market Attractiveness Analysis, By End-user
  • 7.10. Asia Pacific Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.11. Asia Pacific Metabolomics Market Attractiveness Analysis, By Country
    • 7.11.1. China
    • 7.11.2. Japan
    • 7.11.3. South Korea
    • 7.11.4. India
    • 7.11.5. Australia
    • 7.11.6. New Zealand
    • 7.11.7. Singapore
    • 7.11.8. Thailand
    • 7.11.9. Vietnam
    • 7.11.10. Rest of Asia Pacific
• 8. Latin America Metabolomics Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 8.3. Latin America Metabolomics Market Attractiveness Analysis, By Product Type
  • 8.4. Latin America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 8.5. Latin America Metabolomics Market Attractiveness Analysis, By Indication
  • 8.6. Latin America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 8.7. Latin America Metabolomics Market Attractiveness Analysis, By Application
  • 8.8. Latin America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 8.9. Latin America Metabolomics Market Attractiveness Analysis, By End-user
  • 8.10. Latin America Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.11. Latin America Metabolomics Market Attractiveness Analysis, By Country
    • 8.11.1. Brazil
    • 8.11.2. Mexico
    • 8.11.3. Rest of Latin America
• 9. Middle East & Africa Metabolomics Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 9.3. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Product Type
  • 9.4. Middle East & Africa Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 9.5. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Indication
  • 9.6. Middle East & Africa Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 9.7. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Application
  • 9.8. Middle East & Africa Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 9.9. Middle East & Africa Metabolomics Market Attractiveness Analysis, By End-user
  • 9.10. Middle East & Africa Metabolomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.11. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Country
    • 9.11.1. South Africa
    • 9.11.2. Saudi Arabia
    • 9.11.3. UAE
    • 9.11.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Waters Corporation
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Trinity Biotech plc
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Thermo Fisher
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Shimadzu Corporation
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Metabolon
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Bruker
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Biotree
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Agilent
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 2. Global Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 3. Global Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 4. Global Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 5. Global Metabolomics Market Value (US$ Mn), By Region, 2020-2034
• Table 6. North America Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 7. North America Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 8. North America Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 9. North America Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 10. North America Metabolomics Market Value (US$ Mn), By Country, 2020-2034
• Table 11. The US Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 12. The US Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 13. The US Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 14. The US Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 15. Canada Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 16. Canada Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 17. Canada Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 18. Canada Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 19. Europe Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 20. Europe Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 21. Europe Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 22. Europe Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 23. Europe Metabolomics Market Value (US$ Mn), By Country, 2020-2034
• Table 24. Germany Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 25. Germany Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 26. Germany Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 27. Germany Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 28. The UK Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 29. The UK Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 30. The UK Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 31. The UK Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 32. France Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 33. France Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 34. France Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 35. France Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 36. Spain Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 37. Spain Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 38. Spain Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 39. Spain Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 40. Italy Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 41. Italy Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 42. Italy Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 43. Italy Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 44. Russia Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 45. Russia Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 46. Russia Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 47. Russia Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 48. Netherland Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 49. Netherland Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 50. Netherland Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 51. Netherland Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 52. Rest of Europe Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 53. Rest of Europe Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 54. Rest of Europe Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 55. Rest of Europe Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 56. Asia Pacific Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 57. Asia Pacific Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 58. Asia Pacific Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 59. Asia Pacific Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 60. Asia Pacific Metabolomics Market Value (US$ Mn), By Country, 2020-2034
• Table 61. China Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 62. China Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 63. China Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 64. China Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 65. India Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 66. India Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 67. India Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 68. India Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 69. Japan Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 70. Japan Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 71. Japan Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 72. Japan Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 73. South Korea Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 74. South Korea Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 75. South Korea Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 76. South Korea Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 77. Australia Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 78. Australia Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 79. Australia Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 80. Australia Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 81. New Zealand Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 82. New Zealand Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 83. New Zealand Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 84. New Zealand Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 85. Singapore Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 86. Singapore Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 87. Singapore Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 88. Singapore Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 89. Thailand Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 90. Thailand Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 91. Thailand Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 92. Thailand Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 93. Vietnam Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 94. Vietnam Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 95. Vietnam Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 96. Vietnam Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 97. Rest of Asia Pacific Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 98. Rest of Asia Pacific Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 99. Rest of Asia Pacific Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 100. Rest of Asia Pacific Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 101. Latin America Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 102. Latin America Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 103. Latin America Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 104. Latin America Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 105. Latin America Metabolomics Market Value (US$ Mn), By Country, 2020-2034
• Table 106. Brazil Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 107. Brazil Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 108. Brazil Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 109. Brazil Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 110. Mexico Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 111. Mexico Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 112. Mexico Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 113. Mexico Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 114. Rest of Latin America Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 115. Rest of Latin America Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 116. Rest of Latin America Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 117. Rest of Latin America Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 118. Middle East & Africa Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 119. Middle East & Africa Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 120. Middle East & Africa Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 121. Middle East & Africa Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 122. Middle East & Africa Metabolomics Market Value (US$ Mn), By Country, 2020-2034
• Table 123. South Africa Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 124. South Africa Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 125. South Africa Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 126. South Africa Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 127. Saudi Arabia Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 128. Saudi Arabia Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 129. Saudi Arabia Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 130. Saudi Arabia Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 131. UAE Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 132. UAE Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 133. UAE Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 134. UAE Metabolomics Market Value (US$ Mn), By End-user, 2020-2034
• Table 135. Rest of Middle East & Africa Metabolomics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 136. Rest of Middle East & Africa Metabolomics Market Value (US$ Mn), By Indication, 2020-2034
• Table 137. Rest of Middle East & Africa Metabolomics Market Value (US$ Mn), By Application, 2020-2034
• Table 138. Rest of Middle East & Africa Metabolomics Market Value (US$ Mn), By End-user, 2020-2034

List of Figures

• Figure 1. Global Metabolomics Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Metabolomics Market
• Figure 5. Global Metabolomics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 6. Global Metabolomics Market Attractiveness Analysis, By Product Type
• Figure 7. Global Metabolomics Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 8. Global Metabolomics Market Attractiveness Analysis, By Indication
• Figure 9. Global Metabolomics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 10. Global Metabolomics Market Attractiveness Analysis, By Application
• Figure 11. Global Metabolomics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 12. Global Metabolomics Market Attractiveness Analysis, By End-user
• Figure 13. Global Metabolomics Market Analysis, By Region, 2020, 2024 and 2034
• Figure 14. Global Metabolomics Market Attractiveness Analysis, By Region
• Figure 15. North America Metabolomics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 16. North America Metabolomics Market Attractiveness Analysis, By Product Type
• Figure 17. North America Metabolomics Market (US$ Mn), by Metabolomics Instruments, 2020-2034
• Figure 18. North America Metabolomics Market (US$ Mn), by Separation Tools, 2020-2034
• Figure 19. North America Metabolomics Market (US$ Mn), by Detection Tools, 2020-2034
• Figure 20. North America Metabolomics Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 21. North America Metabolomics Market Attractiveness Analysis, By Indication
• Figure 22. North America Metabolomics Market (US$ Mn), by Cancer, 2020-2034
• Figure 23. North America Metabolomics Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 24. North America Metabolomics Market (US$ Mn), by Metabolic Disorders, 2020-2034
• Figure 25. North America Metabolomics Market (US$ Mn), by Cardiovascular Disorders, 2020-2034
• Figure 26. North America Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 27. North America Metabolomics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 28. North America Metabolomics Market Attractiveness Analysis, By Application
• Figure 29. North America Metabolomics Market (US$ Mn), by Biomarker Discovery, 2020-2034
• Figure 30. North America Metabolomics Market (US$ Mn), by Toxicology Testing, 2020-2034
• Figure 31. North America Metabolomics Market (US$ Mn), by Personalized Medicine, 2020-2034
• Figure 32. North America Metabolomics Market (US$ Mn), by Nutrogenomics, 2020-2034
• Figure 33. North America Metabolomics Market (US$ Mn), by Functional Genomics, 2020-2034
• Figure 34. North America Metabolomics Market (US$ Mn), by Drug Discovery, 2020-2034
• Figure 35. North America Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 36. North America Metabolomics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 37. North America Metabolomics Market Attractiveness Analysis, By End-user
• Figure 38. North America Metabolomics Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 39. North America Metabolomics Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 40. North America Metabolomics Market (US$ Mn), by Contract Research Organizations, 2020-2034
• Figure 41. North America Metabolomics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 42. North America Metabolomics Market Attractiveness Analysis, By Country
• Figure 43. Europe Metabolomics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 44. Europe Metabolomics Market Attractiveness Analysis, By Product Type
• Figure 45. Europe Metabolomics Market (US$ Mn), by Metabolomics Instruments, 2020-2034
• Figure 46. Europe Metabolomics Market (US$ Mn), by Separation Tools, 2020-2034
• Figure 47. Europe Metabolomics Market (US$ Mn), by Detection Tools, 2020-2034
• Figure 48. Europe Metabolomics Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 49. Europe Metabolomics Market Attractiveness Analysis, By Indication
• Figure 50. Europe Metabolomics Market (US$ Mn), by Cancer, 2020-2034
• Figure 51. Europe Metabolomics Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 52. Europe Metabolomics Market (US$ Mn), by Metabolic Disorders, 2020-2034
• Figure 53. Europe Metabolomics Market (US$ Mn), by Cardiovascular Disorders, 2020-2034
• Figure 54. Europe Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 55. Europe Metabolomics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 56. Europe Metabolomics Market Attractiveness Analysis, By Application
• Figure 57. Europe Metabolomics Market (US$ Mn), by Biomarker Discovery, 2020-2034
• Figure 58. Europe Metabolomics Market (US$ Mn), by Toxicology Testing, 2020-2034
• Figure 59. Europe Metabolomics Market (US$ Mn), by Personalized Medicine, 2020-2034
• Figure 60. Europe Metabolomics Market (US$ Mn), by Nutrogenomics, 2020-2034
• Figure 61. Europe Metabolomics Market (US$ Mn), by Functional Genomics, 2020-2034
• Figure 62. Europe Metabolomics Market (US$ Mn), by Drug Discovery, 2020-2034
• Figure 63. Europe Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 64. Europe Metabolomics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 65. Europe Metabolomics Market Attractiveness Analysis, By End-user
• Figure 66. Europe Metabolomics Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 67. Europe Metabolomics Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 68. Europe Metabolomics Market (US$ Mn), by Contract Research Organizations, 2020-2034
• Figure 69. Europe Metabolomics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 70. Europe Metabolomics Market Attractiveness Analysis, By Country
• Figure 71. Asia Pacific Metabolomics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 72. Asia Pacific Metabolomics Market Attractiveness Analysis, By Product Type
• Figure 73. Asia Pacific Metabolomics Market (US$ Mn), by Metabolomics Instruments, 2020-2034
• Figure 74. Asia Pacific Metabolomics Market (US$ Mn), by Separation Tools, 2020-2034
• Figure 75. Asia Pacific Metabolomics Market (US$ Mn), by Detection Tools, 2020-2034
• Figure 76. Asia Pacific Metabolomics Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 77. Asia Pacific Metabolomics Market Attractiveness Analysis, By Indication
• Figure 78. Asia Pacific Metabolomics Market (US$ Mn), by Cancer, 2020-2034
• Figure 79. Asia Pacific Metabolomics Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 80. Asia Pacific Metabolomics Market (US$ Mn), by Metabolic Disorders, 2020-2034
• Figure 81. Asia Pacific Metabolomics Market (US$ Mn), by Cardiovascular Disorders, 2020-2034
• Figure 82. Asia Pacific Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 83. Asia Pacific Metabolomics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 84. Asia Pacific Metabolomics Market Attractiveness Analysis, By Application
• Figure 85. Asia Pacific Metabolomics Market (US$ Mn), by Biomarker Discovery, 2020-2034
• Figure 86. Asia Pacific Metabolomics Market (US$ Mn), by Toxicology Testing, 2020-2034
• Figure 87. Asia Pacific Metabolomics Market (US$ Mn), by Personalized Medicine, 2020-2034
• Figure 88. Asia Pacific Metabolomics Market (US$ Mn), by Nutrogenomics, 2020-2034
• Figure 89. Asia Pacific Metabolomics Market (US$ Mn), by Functional Genomics, 2020-2034
• Figure 90. Asia Pacific Metabolomics Market (US$ Mn), by Drug Discovery, 2020-2034
• Figure 91. Asia Pacific Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 92. Asia Pacific Metabolomics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 93. Asia Pacific Metabolomics Market Attractiveness Analysis, By End-user
• Figure 94. Asia Pacific Metabolomics Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 95. Asia Pacific Metabolomics Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 96. Asia Pacific Metabolomics Market (US$ Mn), by Contract Research Organizations, 2020-2034
• Figure 97. Asia Pacific Metabolomics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 98. Asia Pacific Metabolomics Market Attractiveness Analysis, By Country
• Figure 99. Latin America Metabolomics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 100. Latin America Metabolomics Market Attractiveness Analysis, By Product Type
• Figure 101. Latin America Metabolomics Market (US$ Mn), by Metabolomics Instruments, 2020-2034
• Figure 102. Latin America Metabolomics Market (US$ Mn), by Separation Tools, 2020-2034
• Figure 103. Latin America Metabolomics Market (US$ Mn), by Detection Tools, 2020-2034
• Figure 104. Latin America Metabolomics Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 105. Latin America Metabolomics Market Attractiveness Analysis, By Indication
• Figure 106. Latin America Metabolomics Market (US$ Mn), by Cancer, 2020-2034
• Figure 107. Latin America Metabolomics Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 108. Latin America Metabolomics Market (US$ Mn), by Metabolic Disorders, 2020-2034
• Figure 109. Latin America Metabolomics Market (US$ Mn), by Cardiovascular Disorders, 2020-2034
• Figure 110. Latin America Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 111. Latin America Metabolomics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 112. Latin America Metabolomics Market Attractiveness Analysis, By Application
• Figure 113. Latin America Metabolomics Market (US$ Mn), by Biomarker Discovery, 2020-2034
• Figure 114. Latin America Metabolomics Market (US$ Mn), by Toxicology Testing, 2020-2034
• Figure 115. Latin America Metabolomics Market (US$ Mn), by Personalized Medicine, 2020-2034
• Figure 116. Latin America Metabolomics Market (US$ Mn), by Nutrogenomics, 2020-2034
• Figure 117. Latin America Metabolomics Market (US$ Mn), by Functional Genomics, 2020-2034
• Figure 118. Latin America Metabolomics Market (US$ Mn), by Drug Discovery, 2020-2034
• Figure 119. Latin America Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 120. Latin America Metabolomics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 121. Latin America Metabolomics Market Attractiveness Analysis, By End-user
• Figure 122. Latin America Metabolomics Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 123. Latin America Metabolomics Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 124. Latin America Metabolomics Market (US$ Mn), by Contract Research Organizations, 2020-2034
• Figure 125. Latin America Metabolomics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 126. Latin America Metabolomics Market Attractiveness Analysis, By Country
• Figure 127. Middle East & Africa Metabolomics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 128. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Product Type
• Figure 129. Middle East & Africa Metabolomics Market (US$ Mn), by Metabolomics Instruments, 2020-2034
• Figure 130. Middle East & Africa Metabolomics Market (US$ Mn), by Separation Tools, 2020-2034
• Figure 131. Middle East & Africa Metabolomics Market (US$ Mn), by Detection Tools, 2020-2034
• Figure 132. Middle East & Africa Metabolomics Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 133. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Indication
• Figure 134. Middle East & Africa Metabolomics Market (US$ Mn), by Cancer, 2020-2034
• Figure 135. Middle East & Africa Metabolomics Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 136. Middle East & Africa Metabolomics Market (US$ Mn), by Metabolic Disorders, 2020-2034
• Figure 137. Middle East & Africa Metabolomics Market (US$ Mn), by Cardiovascular Disorders, 2020-2034
• Figure 138. Middle East & Africa Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 139. Middle East & Africa Metabolomics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 140. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Application
• Figure 141. Middle East & Africa Metabolomics Market (US$ Mn), by Biomarker Discovery, 2020-2034
• Figure 142. Middle East & Africa Metabolomics Market (US$ Mn), by Toxicology Testing, 2020-2034
• Figure 143. Middle East & Africa Metabolomics Market (US$ Mn), by Personalized Medicine, 2020-2034
• Figure 144. Middle East & Africa Metabolomics Market (US$ Mn), by Nutrogenomics, 2020-2034
• Figure 145. Middle East & Africa Metabolomics Market (US$ Mn), by Functional Genomics, 2020-2034
• Figure 146. Middle East & Africa Metabolomics Market (US$ Mn), by Drug Discovery, 2020-2034
• Figure 147. Middle East & Africa Metabolomics Market (US$ Mn), by Others, 2020-2034
• Figure 148. Middle East & Africa Metabolomics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 149. Middle East & Africa Metabolomics Market Attractiveness Analysis, By End-user
• Figure 150. Middle East & Africa Metabolomics Market (US$ Mn), by Academic & Research Institutes, 2020-2034
• Figure 151. Middle East & Africa Metabolomics Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 152. Middle East & Africa Metabolomics Market (US$ Mn), by Contract Research Organizations, 2020-2034
• Figure 153. Middle East & Africa Metabolomics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 154. Middle East & Africa Metabolomics Market Attractiveness Analysis, By Country